Theratechnologies develops therapies for unmet medical needs in commercially attractive specialty markets.
Theratechnologies (TSX:TH) is a Canadian biopharmaceutical company that discovers novel therapeutic products for development and commercialization. These products target unmet medical needs in commercially attractive specialty markets.
Products
Our lead product: tesamorelin
Antiretrovirals have increased the life expectancy of HIV patients. Despite the benefits of these therapies, they are associated with side-effects such as lipodystrophy. We are currently studying the effects of tesamorelin (TH9507) on excessive visceral fat, an important characteristic of HIV-associated lipodystrophy. More...
Investors
See our investor kit:
First scientific symposium, sponsored by Theratechnologies, at the 11th European AIDS Conference.
Access the symposium's webcast